Structure

Physi-Chem Properties

Molecular Weight:  644.21
Volume:  621.864
LogP:  2.287
LogD:  0.906
LogS:  -2.738
# Rotatable Bonds:  12
TPSA:  222.65
# H-Bond Aceptor:  14
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.079
Synthetic Accessibility Score:  4.734
Fsp3:  0.406
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.124
MDCK Permeability:  4.033153163618408e-05
Pgp-inhibitor:  0.026
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.413
20% Bioavailability (F20%):  0.985
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.115
Plasma Protein Binding (PPB):  92.19754791259766%
Volume Distribution (VD):  0.721
Pgp-substrate:  13.264913558959961%

ADMET: Metabolism

CYP1A2-inhibitor:  0.036
CYP1A2-substrate:  0.201
CYP2C19-inhibitor:  0.037
CYP2C19-substrate:  0.064
CYP2C9-inhibitor:  0.519
CYP2C9-substrate:  0.844
CYP2D6-inhibitor:  0.045
CYP2D6-substrate:  0.207
CYP3A4-inhibitor:  0.475
CYP3A4-substrate:  0.187

ADMET: Excretion

Clearance (CL):  8.709
Half-life (T1/2):  0.735

ADMET: Toxicity

hERG Blockers:  0.302
Human Hepatotoxicity (H-HT):  0.5
Drug-inuced Liver Injury (DILI):  0.492
AMES Toxicity:  0.06
Rat Oral Acute Toxicity:  0.191
Maximum Recommended Daily Dose:  0.935
Skin Sensitization:  0.2
Carcinogencity:  0.426
Eye Corrosion:  0.003
Eye Irritation:  0.008
Respiratory Toxicity:  0.057

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471823

Natural Product ID:  NPC471823
Common Name*:   3'''-O-Demethyltoddalin A
IUPAC Name:   [(2S)-1-(5,7-dimethoxy-2-oxochromen-6-yl)-3-hydroxy-3-methylbutan-2-yl] (1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylate
Synonyms:  
Standard InCHIKey:  CUNNJWDUTDVNSE-ASGIRPLNSA-N
Standard InCHI:  InChI=1S/C32H36O14/c1-31(2,40)25(12-18-22(42-3)13-23-17(29(18)43-4)7-10-27(37)44-23)46-30(39)32(41)14-21(35)28(38)24(15-32)45-26(36)9-6-16-5-8-19(33)20(34)11-16/h5-11,13,21,24-25,28,33-35,38,40-41H,12,14-15H2,1-4H3/b9-6+/t21-,24-,25+,28-,32+/m1/s1
SMILES:  CC(C)(C(CC1=C(C=C2C(=C1OC)C=CC(=O)O2)OC)OC(=O)C3(CC(C(C(C3)OC(=O)C=CC4=CC(=C(C=C4)O)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3235990
PubChem CID:   90655366
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000129] Alcohols and polyols
          • [CHEMONTID:0001292] Cyclic alcohols and derivatives
            • [CHEMONTID:0002509] Cyclitols and derivatives
              • [CHEMONTID:0002512] Quinic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7213 Toddalia asiatica Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[24597921]
NPO7213 Toddalia asiatica Species Rutaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO7213 Toddalia asiatica Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7213 Toddalia asiatica Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO7213 Toddalia asiatica Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1464 Individual Protein Phosphodiesterase 4D Homo sapiens IC50 = 16650.0 nM PMID[470914]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471823 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9172 High Similarity NPC19380
0.9172 High Similarity NPC146277
0.9108 High Similarity NPC93498
0.9108 High Similarity NPC163883
0.9068 High Similarity NPC24164
0.9 High Similarity NPC470896
0.9 High Similarity NPC473275
0.9 High Similarity NPC165483
0.8963 High Similarity NPC142614
0.8957 High Similarity NPC476371
0.8957 High Similarity NPC476372
0.8951 High Similarity NPC53889
0.8944 High Similarity NPC68324
0.8944 High Similarity NPC38779
0.8944 High Similarity NPC114179
0.8944 High Similarity NPC156818
0.8944 High Similarity NPC289322
0.8944 High Similarity NPC160512
0.8938 High Similarity NPC145425
0.8909 High Similarity NPC13481
0.8909 High Similarity NPC207575
0.8896 High Similarity NPC124747
0.8896 High Similarity NPC109061
0.8896 High Similarity NPC155754
0.8889 High Similarity NPC98083
0.8889 High Similarity NPC24339
0.8889 High Similarity NPC87317
0.8889 High Similarity NPC94220
0.8889 High Similarity NPC7543
0.8889 High Similarity NPC166456
0.8882 High Similarity NPC318432
0.8882 High Similarity NPC88803
0.8882 High Similarity NPC250436
0.8882 High Similarity NPC104983
0.8882 High Similarity NPC291948
0.8882 High Similarity NPC300845
0.8876 High Similarity NPC67629
0.8876 High Similarity NPC79736
0.8869 High Similarity NPC476374
0.8862 High Similarity NPC180768
0.8861 High Similarity NPC103116
0.8855 High Similarity NPC158761
0.8855 High Similarity NPC260266
0.8848 High Similarity NPC471788
0.8834 High Similarity NPC476373
0.8824 High Similarity NPC267549
0.881 High Similarity NPC475669
0.881 High Similarity NPC271848
0.881 High Similarity NPC262580
0.881 High Similarity NPC289396
0.881 High Similarity NPC81332
0.881 High Similarity NPC212038
0.881 High Similarity NPC476370
0.8802 High Similarity NPC217378
0.8802 High Similarity NPC280493
0.8795 High Similarity NPC9309
0.8795 High Similarity NPC471213
0.8788 High Similarity NPC472625
0.878 High Similarity NPC289771
0.8758 High Similarity NPC8712
0.8757 High Similarity NPC98583
0.875 High Similarity NPC75695
0.8743 High Similarity NPC470456
0.8742 High Similarity NPC21184
0.8742 High Similarity NPC294522
0.8742 High Similarity NPC120426
0.8742 High Similarity NPC306343
0.8742 High Similarity NPC205727
0.8735 High Similarity NPC470457
0.8735 High Similarity NPC50960
0.8734 High Similarity NPC139839
0.8734 High Similarity NPC187398
0.8734 High Similarity NPC476348
0.8727 High Similarity NPC471745
0.8726 High Similarity NPC98356
0.8721 High Similarity NPC6709
0.8721 High Similarity NPC117668
0.8721 High Similarity NPC208069
0.8718 High Similarity NPC471824
0.8706 High Similarity NPC169645
0.8706 High Similarity NPC84482
0.8698 High Similarity NPC65333
0.8698 High Similarity NPC100251
0.8696 High Similarity NPC474656
0.8683 High Similarity NPC470462
0.8683 High Similarity NPC43065
0.8679 High Similarity NPC42464
0.8679 High Similarity NPC107636
0.8679 High Similarity NPC176903
0.8679 High Similarity NPC30688
0.8675 High Similarity NPC234004
0.8675 High Similarity NPC470459
0.8675 High Similarity NPC227297
0.8671 High Similarity NPC476347
0.8667 High Similarity NPC112418
0.8667 High Similarity NPC177100
0.8667 High Similarity NPC198829
0.8667 High Similarity NPC349525
0.8667 High Similarity NPC472634
0.8667 High Similarity NPC471499
0.8667 High Similarity NPC142252
0.8667 High Similarity NPC139540
0.8667 High Similarity NPC26326
0.8667 High Similarity NPC474038
0.8659 High Similarity NPC117418
0.8659 High Similarity NPC53545
0.8659 High Similarity NPC22192
0.8654 High Similarity NPC472016
0.8654 High Similarity NPC43158
0.8654 High Similarity NPC277315
0.8654 High Similarity NPC192831
0.8654 High Similarity NPC258469
0.8647 High Similarity NPC163165
0.8639 High Similarity NPC476365
0.8634 High Similarity NPC120774
0.8634 High Similarity NPC95498
0.8634 High Similarity NPC264875
0.8634 High Similarity NPC163598
0.8634 High Similarity NPC246566
0.8631 High Similarity NPC243877
0.8631 High Similarity NPC295082
0.8631 High Similarity NPC473818
0.8625 High Similarity NPC473091
0.8623 High Similarity NPC62261
0.8623 High Similarity NPC85057
0.8623 High Similarity NPC130920
0.8621 High Similarity NPC470416
0.8616 High Similarity NPC192568
0.8616 High Similarity NPC43123
0.8616 High Similarity NPC471076
0.8614 High Similarity NPC476247
0.8614 High Similarity NPC8300
0.8614 High Similarity NPC474033
0.8614 High Similarity NPC220912
0.8614 High Similarity NPC472448
0.8614 High Similarity NPC474034
0.8614 High Similarity NPC261470
0.8614 High Similarity NPC83922
0.8608 High Similarity NPC268515
0.8608 High Similarity NPC40222
0.8608 High Similarity NPC287275
0.8606 High Similarity NPC475784
0.8606 High Similarity NPC301089
0.8606 High Similarity NPC24627
0.8606 High Similarity NPC470326
0.8606 High Similarity NPC328102
0.8606 High Similarity NPC476980
0.8606 High Similarity NPC282009
0.8606 High Similarity NPC192686
0.8606 High Similarity NPC119209
0.8606 High Similarity NPC287328
0.8606 High Similarity NPC472630
0.8606 High Similarity NPC118256
0.8606 High Similarity NPC470183
0.8606 High Similarity NPC471744
0.8606 High Similarity NPC472631
0.8605 High Similarity NPC35167
0.8605 High Similarity NPC476773
0.8605 High Similarity NPC168584
0.8599 High Similarity NPC471763
0.8598 High Similarity NPC237418
0.8598 High Similarity NPC125495
0.8596 High Similarity NPC99591
0.8596 High Similarity NPC477848
0.859 High Similarity NPC13818
0.859 High Similarity NPC297517
0.859 High Similarity NPC206095
0.859 High Similarity NPC471027
0.859 High Similarity NPC224389
0.859 High Similarity NPC477335
0.859 High Similarity NPC35702
0.8589 High Similarity NPC222185
0.8588 High Similarity NPC121333
0.8588 High Similarity NPC190003
0.8588 High Similarity NPC175107
0.858 High Similarity NPC475212
0.858 High Similarity NPC177480
0.8563 High Similarity NPC241781
0.8563 High Similarity NPC36138
0.8563 High Similarity NPC156785
0.8563 High Similarity NPC41301
0.8563 High Similarity NPC162394
0.8563 High Similarity NPC45943
0.8563 High Similarity NPC124038
0.8562 High Similarity NPC475250
0.8554 High Similarity NPC472632
0.8554 High Similarity NPC471210
0.8554 High Similarity NPC471211
0.8554 High Similarity NPC473106
0.8554 High Similarity NPC29876
0.8554 High Similarity NPC308992
0.8554 High Similarity NPC158188
0.8554 High Similarity NPC167678
0.8554 High Similarity NPC228383
0.8554 High Similarity NPC259456
0.8554 High Similarity NPC3629
0.8554 High Similarity NPC471212
0.8554 High Similarity NPC103201
0.8554 High Similarity NPC134783
0.8553 High Similarity NPC15577

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471823 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8882 High Similarity NPD4868 Clinical (unspecified phase)
0.8698 High Similarity NPD7993 Clinical (unspecified phase)
0.858 High Similarity NPD5844 Phase 1
0.8535 High Similarity NPD6190 Approved
0.8512 High Similarity NPD6168 Clinical (unspecified phase)
0.8512 High Similarity NPD6167 Clinical (unspecified phase)
0.8512 High Similarity NPD6166 Phase 2
0.8488 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8485 Intermediate Similarity NPD7075 Discontinued
0.8415 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8364 Intermediate Similarity NPD3817 Phase 2
0.8354 Intermediate Similarity NPD6801 Discontinued
0.8343 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8324 Intermediate Similarity NPD7251 Discontinued
0.8304 Intermediate Similarity NPD3818 Discontinued
0.8303 Intermediate Similarity NPD2801 Approved
0.8303 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8276 Intermediate Similarity NPD7808 Phase 3
0.8266 Intermediate Similarity NPD6797 Phase 2
0.8256 Intermediate Similarity NPD7054 Approved
0.8256 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8253 Intermediate Similarity NPD5402 Approved
0.8242 Intermediate Similarity NPD1934 Approved
0.8232 Intermediate Similarity NPD4380 Phase 2
0.8208 Intermediate Similarity NPD7472 Approved
0.8208 Intermediate Similarity NPD7074 Phase 3
0.8204 Intermediate Similarity NPD3882 Suspended
0.8193 Intermediate Similarity NPD1465 Phase 2
0.811 Intermediate Similarity NPD1653 Approved
0.8098 Intermediate Similarity NPD1512 Approved
0.8084 Intermediate Similarity NPD7819 Suspended
0.807 Intermediate Similarity NPD6232 Discontinued
0.8047 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8037 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8035 Intermediate Similarity NPD7473 Discontinued
0.8011 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6234 Discontinued
0.7989 Intermediate Similarity NPD7228 Approved
0.7975 Intermediate Similarity NPD1511 Approved
0.7964 Intermediate Similarity NPD7411 Suspended
0.7953 Intermediate Similarity NPD5494 Approved
0.7939 Intermediate Similarity NPD5403 Approved
0.7929 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD37 Approved
0.7907 Intermediate Similarity NPD7199 Phase 2
0.7901 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD1613 Approved
0.7886 Intermediate Similarity NPD3751 Discontinued
0.7885 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD4967 Phase 2
0.7882 Intermediate Similarity NPD4966 Approved
0.7882 Intermediate Similarity NPD4965 Approved
0.7882 Intermediate Similarity NPD7768 Phase 2
0.7866 Intermediate Similarity NPD6799 Approved
0.7818 Intermediate Similarity NPD5401 Approved
0.7809 Intermediate Similarity NPD7685 Pre-registration
0.7803 Intermediate Similarity NPD8127 Discontinued
0.7791 Intermediate Similarity NPD919 Approved
0.7771 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7759 Intermediate Similarity NPD3787 Discontinued
0.7742 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD230 Phase 1
0.7736 Intermediate Similarity NPD5124 Phase 1
0.7736 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7709 Intermediate Similarity NPD6559 Discontinued
0.7707 Intermediate Similarity NPD3027 Phase 3
0.7692 Intermediate Similarity NPD8150 Discontinued
0.7692 Intermediate Similarity NPD6599 Discontinued
0.7692 Intermediate Similarity NPD8434 Phase 2
0.7683 Intermediate Similarity NPD4628 Phase 3
0.7683 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD3750 Approved
0.7661 Intermediate Similarity NPD8455 Phase 2
0.7658 Intermediate Similarity NPD6798 Discontinued
0.7643 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD6233 Phase 2
0.7607 Intermediate Similarity NPD7266 Discontinued
0.76 Intermediate Similarity NPD1247 Approved
0.76 Intermediate Similarity NPD6959 Discontinued
0.758 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1549 Phase 2
0.7557 Intermediate Similarity NPD7229 Phase 3
0.7546 Intermediate Similarity NPD2796 Approved
0.7546 Intermediate Similarity NPD2935 Discontinued
0.7545 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD3749 Approved
0.7527 Intermediate Similarity NPD8312 Approved
0.7527 Intermediate Similarity NPD8313 Approved
0.7516 Intermediate Similarity NPD6355 Discontinued
0.7514 Intermediate Similarity NPD7240 Approved
0.75 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7435 Discontinued
0.7485 Intermediate Similarity NPD7033 Discontinued
0.7485 Intermediate Similarity NPD1510 Phase 2
0.7473 Intermediate Similarity NPD7549 Discontinued
0.7453 Intermediate Similarity NPD4060 Phase 1
0.7438 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD3226 Approved
0.7412 Intermediate Similarity NPD920 Approved
0.7411 Intermediate Similarity NPD7783 Phase 2
0.7411 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD1652 Phase 2
0.7396 Intermediate Similarity NPD2534 Approved
0.7396 Intermediate Similarity NPD2532 Approved
0.7396 Intermediate Similarity NPD2533 Approved
0.7378 Intermediate Similarity NPD3748 Approved
0.7375 Intermediate Similarity NPD7095 Approved
0.7365 Intermediate Similarity NPD8166 Discontinued
0.736 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD7874 Approved
0.7349 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD7585 Approved
0.7344 Intermediate Similarity NPD6781 Approved
0.7344 Intermediate Similarity NPD6782 Approved
0.7344 Intermediate Similarity NPD6779 Approved
0.7344 Intermediate Similarity NPD6776 Approved
0.7344 Intermediate Similarity NPD6777 Approved
0.7344 Intermediate Similarity NPD6778 Approved
0.7344 Intermediate Similarity NPD6780 Approved
0.7342 Intermediate Similarity NPD2797 Approved
0.7333 Intermediate Similarity NPD6100 Approved
0.7333 Intermediate Similarity NPD6099 Approved
0.7329 Intermediate Similarity NPD3268 Approved
0.7326 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD7697 Approved
0.732 Intermediate Similarity NPD7696 Phase 3
0.732 Intermediate Similarity NPD7698 Approved
0.7318 Intermediate Similarity NPD3926 Phase 2
0.7317 Intermediate Similarity NPD7097 Phase 1
0.7312 Intermediate Similarity NPD4908 Phase 1
0.731 Intermediate Similarity NPD8151 Discontinued
0.7308 Intermediate Similarity NPD422 Phase 1
0.7301 Intermediate Similarity NPD447 Suspended
0.7296 Intermediate Similarity NPD7583 Approved
0.7294 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD7870 Phase 2
0.7282 Intermediate Similarity NPD7871 Phase 2
0.7278 Intermediate Similarity NPD3225 Approved
0.7268 Intermediate Similarity NPD5953 Discontinued
0.7259 Intermediate Similarity NPD7701 Phase 2
0.7253 Intermediate Similarity NPD7286 Phase 2
0.7239 Intermediate Similarity NPD1240 Approved
0.7239 Intermediate Similarity NPD943 Approved
0.7231 Intermediate Similarity NPD7680 Approved
0.7229 Intermediate Similarity NPD1551 Phase 2
0.7225 Intermediate Similarity NPD7458 Discontinued
0.7202 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD1243 Approved
0.7176 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD4308 Phase 3
0.716 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1607 Approved
0.7151 Intermediate Similarity NPD6273 Approved
0.715 Intermediate Similarity NPD7700 Phase 2
0.715 Intermediate Similarity NPD7801 Approved
0.715 Intermediate Similarity NPD7699 Phase 2
0.7143 Intermediate Similarity NPD2424 Discontinued
0.7127 Intermediate Similarity NPD5242 Approved
0.7121 Intermediate Similarity NPD7584 Approved
0.7119 Intermediate Similarity NPD5353 Approved
0.7117 Intermediate Similarity NPD2313 Discontinued
0.7112 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD8320 Phase 1
0.7107 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD8319 Approved
0.7101 Intermediate Similarity NPD6674 Discontinued
0.7099 Intermediate Similarity NPD6832 Phase 2
0.7088 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD5762 Approved
0.7083 Intermediate Similarity NPD6535 Approved
0.7083 Intermediate Similarity NPD5763 Approved
0.7083 Intermediate Similarity NPD6534 Approved
0.7077 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD4062 Phase 3
0.7066 Intermediate Similarity NPD2799 Discontinued
0.7055 Intermediate Similarity NPD4625 Phase 3
0.7051 Intermediate Similarity NPD1548 Phase 1
0.7045 Intermediate Similarity NPD6386 Approved
0.7045 Intermediate Similarity NPD6385 Approved
0.7044 Intermediate Similarity NPD9269 Phase 2
0.7044 Intermediate Similarity NPD1608 Approved
0.7043 Intermediate Similarity NPD7039 Approved
0.7043 Intermediate Similarity NPD7038 Approved
0.7041 Intermediate Similarity NPD2493 Approved
0.7041 Intermediate Similarity NPD2494 Approved
0.7037 Intermediate Similarity NPD9494 Approved
0.7019 Intermediate Similarity NPD3267 Approved
0.7019 Intermediate Similarity NPD3266 Approved
0.7012 Intermediate Similarity NPD1296 Phase 2
0.7012 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD6823 Phase 2
0.7005 Intermediate Similarity NPD8155 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data